identified DOCK9, PTGFR, NREP, SCARNA22, FLVCR2, CLASP1, IK2F3, and USP13 as potential biomarkers predicting the progression of PCa, especially between stage II and subsequent stages (123). Here, USP13 is linked to posterior cortical atrophy.